Lb Pharmaceuticals
(NASDAQ) LBRX
Lb Pharmaceuticals Financials at a Glance
Market Cap
$814.99M
Revenue (TTM)
$0.00
Net Income (TTM)
-$39.17M
EPS (TTM)
-$1.49
P/E Ratio
-19.13
Dividend
$0.00
Beta (Volatility)
1.03 (Average)
Dividend
$0.00
Beta (Volatility)
1.03 (Average)
Price
$28.37
Volume
127,199.085
Open
$28.55
Price
$28.37
Volume
127,199.085
Open
$28.55
Previous Close
$28.42
Daily Range
$28.20 - $29.22
52-Week Range
$13.36 - $33.47
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
1.03 (Average)
Price
$28.37
Volume
127,199.085
Open
$28.55
Previous Close
$28.42
Daily Range
$28.20 - $29.22
52-Week Range
$13.36 - $33.47
Estimated Earnings Date
Aug 11, 2026
LBRX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lb Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
27
CEO
Heather D. Turner
Website
www.lbpharma.usHeadquarters
New York, NY 10119, US
LBRX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-16%
Return on Capital
-12%
Return on Assets
-10%
Earnings Yield
-5.23%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$814.99M
Shares Outstanding
28.68M
Volume
127.20K
Avg. Volume
233.45K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$30.40M
EBITDA
-$24.88M
Operating Cash Flow
-$35.21M
Capital Expenditure
-$52.00K
Free Cash Flow
-$35.26M
Cash & ST Invst.
$295.21M
Total Debt
$3.57M
Lb Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$82.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$814.99M
N/A
Market Cap/Employee
$50.94M
N/A
Employees
16
N/A
Net Income
-$19.05M
-274.5%
EBITDA
-$18.97M
-263.7%
Quarterly Fundamentals
Total Cash
$365.64M
+2470.4%
Total Debt
$3.47M
-7.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$2.74M
-9.6%
Short Term Debt
$730.00K
+0.0%
Return on Assets
-9.95%
N/A
Return on Invested Capital
-12.25%
N/A
Free Cash Flow
-$23.32M
-186.2%
Operating Cash Flow
-$23.29M
-186.5%